Gilead Sciences (GILD) Income Statement

Click line-items for a historical chart and %

Revenues:
Product sales	7.41B
Royalty revenues
Contract and other revenues
Total revenues
Costs and expenses:
Cost of goods sold	1.13B
Research and development
Selling, general and administrative	831M
Total costs and expenses	3.1B
Income from operations	4.4B
Interest and other income, net	119M
Interest expense	-242M
Income before provision for income taxes	4.28B
Provision for income taxes	951M
Net income	3.33B
Net loss attributable to noncontrolling interest	-5M
Net income attributable to Gilead	3.33B
Net income per share attributable to Gilead common stockholders- basic	2.52
Shares used in per share calculation - basic	1.32B
Net income per share attributable to Gilead common stockholders - diluted	2.49
Shares used in per share calculation - diluted	1.34B

Entities mentioned with GILD